Results 281 to 290 of about 2,364,373 (300)

Immunomodulatory therapy to preserve pancreatic β-cell function in type 1 diabetes

Nature Reviews Drug Discovery, 2011
Frank D Waldron-Lynch
exaly  

Targeting hepatic glucose metabolism in the treatment of type 2 diabetes

Nature Reviews Drug Discovery, 2016
Kfir Sharabi, Pere Puigserver, Bradley E Bernstein   +2 more
exaly  

Type 2 diabetes as an inflammatory disease

Nature Reviews Immunology, 2011
Marc Y Donath, Steven E Shoelson
exaly  

Type 2 diabetes mellitus after gestational diabetes: a systematic review and meta-analysis

Lancet, The, 2009
Aroon D Hingorani, David Williams
exaly  

Type 2 diabetes

Lancet, The, 2017
Sudesna Chatterjee, Kamlesh Khunti, Melanie J Davies   +2 more
exaly  

Intake of vitamin D and risk of type 1 diabetes: a birth-cohort study

Lancet, The, 2001
Elina Hypponen, Marjo-Riitta Jarvelin, Suvi M Virtanen   +2 more
exaly  

Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial

Lancet, The, 2019
Hertzel C Gerstein, Helen Colhoun, Gilles R Dagenais   +2 more
exaly  

Managing diabetes with nanomedicine: challenges and opportunities

Nature Reviews Drug Discovery, 2014
Omid Veiseh, Benjamin C Tang, Kathryn A Whitehead   +2 more
exaly  

Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes

New England Journal of Medicine, 2015
Bernard Zinman Cm, Christoph Wanner, John M Lachin   +2 more
exaly  

Primary care-led weight management for remission of type 2 diabetes (DiRECT): an open-label, cluster-randomised trial

Lancet, The, 2018
Naomi Brosnahan, George Thom, Louise Mccombie   +2 more
exaly